- Home
- YMAB vs TBLD Comparison
YMAB vs TBLD Comparison
Compare YMAB & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- TBLD
- Stock Information
- Founded
- YMAB 2015
- TBLD 2021
- Country
- YMAB United States
- TBLD United States
- Employees
- YMAB N/A
- TBLD N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- TBLD Investment Managers
- Sector
- YMAB Health Care
- TBLD Finance
- Exchange
- YMAB Nasdaq
- TBLD Nasdaq
- Market Cap
- YMAB 482.4M
- TBLD 530.3M
- IPO Year
- YMAB 2018
- TBLD N/A
- Fundamental
- Price
- YMAB $6.19
- TBLD $17.04
- Analyst Decision
- YMAB Strong Buy
- TBLD
- Analyst Count
- YMAB 10
- TBLD 0
- Target Price
- YMAB $21.10
- TBLD N/A
- AVG Volume (30 Days)
- YMAB 417.3K
- TBLD 99.9K
- Earning Date
- YMAB 02-27-2025
- TBLD 01-01-0001
- Dividend Yield
- YMAB N/A
- TBLD 7.85%
- EPS Growth
- YMAB N/A
- TBLD N/A
- EPS
- YMAB N/A
- TBLD N/A
- Revenue
- YMAB $84,553,000.00
- TBLD N/A
- Revenue This Year
- YMAB $6.09
- TBLD N/A
- Revenue Next Year
- YMAB $19.62
- TBLD N/A
- P/E Ratio
- YMAB N/A
- TBLD N/A
- Revenue Growth
- YMAB N/A
- TBLD N/A
- 52 Week Low
- YMAB $6.01
- TBLD $13.44
- 52 Week High
- YMAB $20.90
- TBLD $16.26
- Technical
- Relative Strength Index (RSI)
- YMAB 19.68
- TBLD 67.14
- Support Level
- YMAB $6.05
- TBLD $16.19
- Resistance Level
- YMAB $6.81
- TBLD $16.50
- Average True Range (ATR)
- YMAB 0.49
- TBLD 0.24
- MACD
- YMAB -0.02
- TBLD 0.09
- Stochastic Oscillator
- YMAB 6.90
- TBLD 86.73
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About TBLD Thornburg Income Builder Opportunities Trust
Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.